Partner testing with HIV self-test distribution by Ugandan pregnant women living with HIV: a randomized trial.
ART
Africa
HIVST
PrEP
male partners
secondary distribution
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
20
10
2022
accepted:
17
08
2023
medline:
8
9
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
ppublish
Résumé
Secondary distribution of HIV self-tests (HIVST) by HIV-negative pregnant women to male partners increases men's testing rates. We examined whether this strategy promotes male partner testing for pregnant women living with HIV (PWLHIV). We conducted an open-label individually randomized trial in Kampala, Uganda, in which PWLHIV ≥18 years who reported a partner of unknown HIV status were randomized 2:1 to secondary distribution of HIVST for male partner(s) or standard-of-care (SOC; invitation letter to male partner for fast-track testing). Women were followed until 12 months post-partum. Male partners were offered confirmatory HIV testing and facilitated linkage to antiretroviral treatment (ART) or oral pre-exposure prophylaxis (PrEP). Using intention-to-treat analysis, primary outcomes were male partner testing at the clinic and initiation on PrEP or ART evaluated through 12 months post-partum (ClinicalTrials.gov, NCT03484533). From November 2018 to March 2020, 500 PWLHIV were enrolled with a median age of 27 years (interquartile range [IQR] 23-30); 332 were randomized to HIVST and 168 to SOC with 437 PWLHIV (87.4%) completing 12 months follow-up post-partum. Of 236 male partners who tested at the clinic and enrolled (47.2%), their median age was 31 years (IQR 27-36), 45 (88.3%) men with HIV started ART and 113 (61.1%) HIV-negative men started PrEP. There was no intervention effect on male partner testing (hazard ratio [HR] 1.04; 95% confidence interval [CI]: 0.79-1.37) or time to ART or PrEP initiation (HR 0.96; 95% CI: 0.69-1.33). Two male partners and two infants acquired HIV for an incidence of 0.99 per 100 person-years (95% CI: 0.12-3.58) and 1.46 per 100 person-years (95% CI: 0.18%-5.28%), respectively. Social harms related to study participation were experienced by six women (HIVST = 5, SOC = 1). Almost half of the partners of Ugandan PWLHIV tested for HIV with similar HIV testing rates and linkage to ART or PrEP among the secondary distribution of HIVST and SOC arms. Although half of men became aware of their HIV serostatus and linked to services, additional strategies to reach male partners of women in antenatal care are needed to increase HIV testing and linkage to services among men.
Identifiants
pubmed: 37675834
doi: 10.1002/jia2.26156
pmc: PMC10483500
doi:
Substances chimiques
Anti-Retroviral Agents
0
Banques de données
ClinicalTrials.gov
['NCT03484533']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26156Subventions
Organisme : NIMH NIH HHS
ID : R01MH113434
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002317
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002318
Pays : United States
Informations de copyright
© 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
Afr J AIDS Res. 2017 Jul;16(2):101-107
pubmed: 28565973
Open Forum Infect Dis. 2018 May 02;5(6):ofy097
pubmed: 29977957
J Int AIDS Soc. 2011 Apr 26;14:21
pubmed: 21521511
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):123-131
pubmed: 28737591
J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):279-284
pubmed: 27828878
PLoS Med. 2016 Nov 8;13(11):e1002166
pubmed: 27824882
PLoS One. 2013;8(1):e55013
pubmed: 23383037
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219847199
pubmed: 31104543
PLoS One. 2020 Nov 9;15(11):e0242001
pubmed: 33166351
J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):379-386
pubmed: 30939530
AIDS Care. 2015;27 Suppl 1:59-64
pubmed: 26616126
Front Public Health. 2021 Feb 19;9:594298
pubmed: 33681120
PLoS One. 2019 Jul 26;14(7):e0219967
pubmed: 31348782
Int J Surg. 2011;9(8):672-7
pubmed: 22019563
EClinicalMedicine. 2021 Jul 07;38:100991
pubmed: 34278282
Afr J Lab Med. 2016 Oct 17;5(2):447
pubmed: 28879125
Lancet Glob Health. 2021 Jul;9(7):e977-e988
pubmed: 34143996
Lancet Glob Health. 2021 Dec;9(12):e1719-e1729
pubmed: 34735862
SAHARA J. 2015;12:87-105
pubmed: 26726756
BMC Public Health. 2022 Nov 24;22(1):2170
pubmed: 36434555
Syst Rev. 2013 Jan 16;2:5
pubmed: 23320454
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):271-279
pubmed: 32168168